Cargando…
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis
Smoking cessation prolongs survival and decreases mortality of patients with non‐small‐cell lung cancer (NSCLC). In addition, epigenetic alterations of some genes are associated with survival. However, potential interactions between smoking cessation and epigenetics have not been assessed. Here, we...
Autores principales: | Zhang, Ruyang, Lai, Linjing, Dong, Xuesi, He, Jieyu, You, Dongfang, Chen, Chao, Lin, Lijuan, Zhu, Ying, Huang, Hui, Shen, Sipeng, Wei, Liangmin, Chen, Xin, Guo, Yichen, Liu, Liya, Su, Li, Shafer, Andrea, Moran, Sebastian, Fleischer, Thomas, Bjaanæs, Maria Moksnes, Karlsson, Anna, Planck, Maria, Staaf, Johan, Helland, Åslaug, Esteller, Manel, Wei, Yongyue, Chen, Feng, Christiani, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487703/ https://www.ncbi.nlm.nih.gov/pubmed/30924596 http://dx.doi.org/10.1002/1878-0261.12482 |
Ejemplares similares
-
Epigenome‐wide three‐way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early‐stage NSCLC
por: Ji, Xinyu, et al.
Publicado: (2022) -
Epigenetic–smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early‐stage NSCLC patients
por: Ji, Xinyu, et al.
Publicado: (2020) -
Epigenome-wide gene–age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients
por: Chen, Chao, et al.
Publicado: (2020) -
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects
por: Zhang, Ruyang, et al.
Publicado: (2020) -
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
por: Dong, Xuesi, et al.
Publicado: (2019)